Similar Articles
281 Comprehensive analysis of the protein phosphatase 2A regulatory subunit B56ε in pan-cancer and its role and mechanism in hepatocellular carcinoma
282 Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine
283 Current status of magnetic resonance imaging radiomics in hepatocellular carcinoma: A quantitative review with Radiomics Quality Score
284 Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study
285 Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease
286 Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis
287 Novel prognostic factors after radical resection of hepatocellular carcinoma: Updating an old issue
288 Predictive value of NLR, Fib4, and APRI in the occurrence of liver failure after hepatectomy in patients with hepatocellular carcinoma
289 Fatty acid binding protein 5 is a novel therapeutic target for hepatocellular carcinoma
290 What are the changes in the hotspots and frontiers of microRNAs in hepatocellular carcinoma over the past decade?
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA